Physician profile
Zair Fishkin
NPI 1073763165
$65,304.41
in general payments reported to CMS, 2019-2025
12 companies · $6,980 in 2025
The $6,980 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $11K · 2021: $9,743 · 2022: $7,793 · 2023: $7,630 · 2024: $5,463 · 2025: $6,980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $19K · Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $19,118.87 |
| Food and Beverage | $954.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $63,602.57 | 2019-2025 | Magnify-S / Magnify, Magnify |
| Medtronic, INC. | $780.16 | 2021-2025 | O-Arm, Catalyft Pl Expandable Interbody System, Unid_pass |
| Abbott Laboratories | $293.48 | 2024 | Octrode, Proclaim |
| Medtronic USA, INC. | $207.58 | 2019-2020 | |
| Providence Medical Technology, INC. | $143.07 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $98.49 | 2022 | |
| Axogen | $48.41 | 2023 | Avance Nerve Graft |
| Horizon Therapeutics Plc | $37.93 | 2022 | |
| Cutting Edge Spine, LLC | $24.58 | 2019 | |
| Avanos Medical | $24.46 | 2020 | |
| Pacira Therapeutics, INC. | $21.93 | 2019 | |
| Orthofix Medical, INC. | $21.75 | 2023 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zair Fishkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.